Circulating tumor cells (CTCs) are cancer cells that are released from a tumor into the
bloodstream. The presence of CTCs in peripheral blood has been associated with …

Circulating tumor cells (CTCs) are prognostic in all stages of breast cancer. However, since
they are extremely rare, little is known about the molecular nature of these cells. We report a …

Purpose: Molecular characterization of circulating tumor cells (CTC) holds great promise.
Unfortunately, routinely isolated CTC fractions currently still contain contaminating …

The availability of blood-based diagnostic testing using a non-invasive technique holds
promise for real-time monitoring of disease progression and treatment selection. Circulating …

Metastases from primary tumors are responsible for most cancer deaths. It has been shown
that circulating tumor cells (CTCs) can be detected in the peripheral blood of patients with a …

Liquid biopsy isolation of circulating tumor cells (CTCs) allows the genomic analysis of
CTCs, which is useful in the determination of personalized cancer therapy. In the present …

Circulating tumor cells (CTCs) are becoming a scientifically recognized indicator of primary
tumors and/or metastasis. These cells can now be accurately detected and characterized as …

The study of circulating tumor cells (CTCs) has a huge clinical interest in advance and
metastatic breast cancer patients. However, many approaches are biased by the use of …

Abstract Blood testing using Circulating Tumor Cells (CTCs) has emerged as one of the
hottest fields in cancer diagnosis. Research on CTCs present nowadays a challenge, as …

Although TNM staging based on tumor, node lymph status and metastasis status—is the
most widely used method in the clinic to classify breast cancer (BC) and assess prognosis, it …